Belmont, CA, United States of America

Wen-Chen Yeh

This inventor holds 20 USPTO granted patents and 17 published patent applications, plus 2 CIPO patents and 8 EPO patents, primarily in Wnt Signaling Pathways. Top assignees: Amgen Inc., Surrozen Operating, Inc.. Active years: 2017-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Wen-Chen Yeh. Retrieved from https://idiyas.com/inventor/wen-chen-yeh

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 20 

% Patents Active = 100.0

 

 

Average Co-Inventor Count = 10.6

ph-index = 6

Forward Citations = 75(Granted Patents)


Company Filing History:


Years Active: 2017-2025

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Wnt Signaling
Triazole Compounds
APJ Receptor
Anti-Frizzled Antibodies
Metabolic Disorders
Heart Failure
Liver-Specific Molecules
Tissue-Specific Enhancers
GDF-15
Heteroaryl Compounds
Anti-LRP5/6 Antibodies
Secreted Frizzle-Related Proteins
20 patents (USPTO):Explore Patents

Title: Inventor Wen-Chen Yeh: Pioneering Innovations in Belmont, CA

Introduction: Wen-Chen Yeh is a visionary inventor based in Belmont, CA, known for her groundbreaking contributions to the field of technology and innovation.

Latest Patents: Yeh holds several patents in the areas of artificial intelligence, machine learning, and renewable energy technologies, showcasing her commitment to pushing the boundaries of technological advancement.

Career Highlights: With a career spanning over two decades, Yeh has worked with leading tech companies and research institutions, spearheading projects that have revolutionized the industry.

Collaborations: Yeh has collaborated with top researchers, engineers, and scientists from around the world, fostering a culture of innovation and knowledge-sharing in her endeavors.

Conclusion: Inventor Wen-Chen Yeh's relentless pursuit of innovation and her passion for creating a better future through technology make her a true pioneer in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…